Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
boston blog main
boston top stories
cancer
deals
life sciences
national blog main
national top stories
san francisco
san francisco blog main
san francisco top stories
startups
adeno-associated virus
alexandria venture investments
altitude life science ventures
american society of gene and cell therapy
amgen
arch venture partners
battlefield
boxer capital
cancer drugs
clinical trials
cobimetinib
disease
disrupt sf 2017
dravet syndrome
ed kaye
encoded therapeutics
events
gene therapy
generation bio
health
hemophilia
illumina
illumina ventures
investing
ipo
matrix capital management
medicine
menlo ventures
What
despite
3
×
cancer
treatment
available
consequence
critical
crude
cutting
day
determining
dozens
drug
edge
effects
encoded
family
gene
great
guesswork
hardest
having
help
hit
hottest
hunters
illumina’s
important
ipo
lasting
late
limited
limits
long
matters
medicine
medicines
miscalculate
nabs
ourotech
path
Language
unset
Current search:
despite
×
biotech
×
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits
@techcrunch.com
6 years ago
Ourotech is taking the guesswork out of cancer treatment
